Snapshot

DOI:

Continue learning with EuroIntervention!

With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.

Short DAPT after NSTE-ACS in HBR patients

Davide Cao, Roxana Mehran and colleagues compare the impact of 1 versus 3 months of dual antiplatelet therapy on the clinical outcomes of high bleeding risk patients undergoing percutaneous coronary intervention (PCI) due to non-ST-segment elevation acute coronary syndrome or chronic coronary syndrome. In their findings, a very short duration of dual antiplatelet therapy appears to be a valid bleeding avoidance strategy for these patients.

Early discharge after large-bore CTO PCI

Same-day discharge can augment patient comfort and decrease economic costs, but is this a feasible and safe practice for patients undergoing large-bore chronic total occlusion PCI? Yvemarie B.O. Somsen, Paul Knaapen and colleagues examine a CTO PCI registry and find that same-day discharge was achieved successfully in over 60% of patients, with low rates of overall vascular access complications.

Impact of calcium morphologies on IVL efficacy

Although calcium modification is recommended before stenting, do different calcium morphologies impact the efficacy of intravascular lithotripsy? Angela McInerney, Nieves Gonzalo and colleagues use optical coherence tomography to assess final stent parameters in patients undergoing intravascular lithotripsy for the treatment of calcified coronary artery disease.

Ultrathin-strut versus thin-strut BP-SES: healing and outcomes

Ryutaro Ikegami, Farouc A. Jaffer and colleagues study how the strut thickness of ultrathin-strut versus thin-strut biodegradable-polymer sirolimus-eluting stents impacts vessel healing and clinical outcomes at 30 days and 1 year. Given that the clinical outcomes were similar, they postulate that the benefits of biodegradable-polymer sirolimus-eluting stents may be independent of the strut thickness.

Volume 20 Number 10
May 20, 2024
Volume 20 Number 10
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.6

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.6

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved